Evaluation of eryptosis in patients with chronic kidney disease.
Mehmet Gokhan GokSaime PaydasBaris BoralEngin OnanBulent KayaPublished in: International urology and nephrology (2022)
In conclusion, our findings revealed the presence accelerated eryptosis, as a potential contributing factor to development of anemia, in patients with CKD stages 3-5D. Inflamation and parathormon can also accelerate eryptosis. Favorable effect of CCB and EPO on eryptosis needs to be confirmed in larger scale studies.
Keyphrases